European Parliament
Diogo Feio  (PPE ),
in writing.
(PT)
Traditionally, vaccination against bluetongue was done with live attenuated virus vaccines, which involved a whole series of restrictions on vaccination in order to keep the virus from spreading to unvaccinated animals. However, scientific developments have allowed the creation of new, inactivated vaccines. Unlike live attenuated vaccines, these can be safely used without restrictions, since they pose no risk of any active virus circulating. In view of the grave effects of bluetongue on livestock farming, every means that makes vaccination easier and more effective should be adopted, to protect farmers against losing their stock and ultimately to guarantee food safety.

